Key Laboratory of Animal Microbiology of China's Ministry of Agriculture, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China.
Hospital of Nanjing Agricultural University, Nanjing 210095, China.
J Immunol Res. 2019 Jan 6;2019:1574383. doi: 10.1155/2019/1574383. eCollection 2019.
The bursa of Fabricius is an acknowledged central humoral immune organ unique to birds, which is vital to B cell differentiation and antibody production. However, the function and mechanism of the biological active peptide isolated from bursa on B cell development and autophagy were less reported. In this study, we isolated a new oligopeptide with nine amino acids Leu-Met-Thr-Phe-Arg-Asn-Glu-Gly-Thr from avian bursa following RP-HPLC, MODIL-TOP-MS, and MS/MS, which was named after BP9. The results of immunization experiments showed that mice injected with 0.01 and 0.05 mg/mL BP9 plus JEV vaccine generated the significant increased antibody levels, compared to those injected with JEV vaccine only. The microarray analysis on the molecular basis of BP9-treated immature B cell showed that vast genes were involved in various immune-related biological processes in BP9-treated WEHI-231 cells, among which the regulation of cytokine production and T cell activation were both major immune-related processes in WEHI-231 cells with BP9 treatment following network analysis. Also, the differentially regulated genes were found to be involved in four significantly enriched pathways in BP9-treated WEHI-231 cells. Finally, we proved that BP9 induced the autophagy formation, regulated the gene and protein expressions related to autophagy in immature B cell, and stimulated AMPK-ULK1 phosphorylation expression. These results suggested that BP9 might be a strong bursal-derived active peptide on antibody response, B cell differentiation, and autophagy in immature B cells, which provided the linking among humoral immunity, B cell differentiation, and autophagy and offered the important reference for the effective immunotherapeutic strategies and immune improvement.
法氏囊是一种公认的鸟类特有的中枢体液免疫器官,对 B 细胞分化和抗体产生至关重要。然而,从法氏囊中分离得到的具有生物活性的肽对 B 细胞发育和自噬的功能和机制的报道较少。在本研究中,我们采用 RP-HPLC、MODIL-TOP-MS 和 MS/MS 从禽类法氏囊中分离得到一种新的九肽,命名为 BP9,其氨基酸序列为 Leu-Met-Thr-Phe-Arg-Asn-Glu-Gly-Thr。免疫实验结果表明,与单独注射 JEV 疫苗的小鼠相比,注射 0.01 和 0.05mg/mL BP9 加 JEV 疫苗的小鼠产生了显著增加的抗体水平。BP9 处理未成熟 B 细胞的分子基础的微阵列分析表明,大量基因参与了 BP9 处理的 WEHI-231 细胞中的各种免疫相关的生物过程,其中,在网络分析后,BP9 处理 WEHI-231 细胞中细胞因子产生和 T 细胞激活的调节是主要的免疫相关过程。此外,差异调节基因被发现参与了 BP9 处理的 WEHI-231 细胞中四个显著富集的途径。最后,我们证明 BP9 诱导了自噬的形成,调节了未成熟 B 细胞中与自噬相关的基因和蛋白的表达,并刺激了 AMPK-ULK1 磷酸化的表达。这些结果表明,BP9 可能是一种强大的法氏囊来源的活性肽,对未成熟 B 细胞的抗体反应、B 细胞分化和自噬具有调节作用,为体液免疫、B 细胞分化和自噬之间的联系提供了重要参考,为有效的免疫治疗策略和免疫改善提供了重要参考。